01 Growing Adoption of Connected and Continuous Home Monitoring Devices Integration with smartphones, cloud platforms, and clinical systems is further improving the ability of healthcare professionals to follow patients remotely and identify changes that may require intervention. In June 2026, the U.S. FDA authorized several sensor-based digital health technologies suitable for monitoring outside clinical settings. These included Dexcom's Stelo Glucose Biosensor System on June 12 and Vivaquant's RX-1 Sleep monitoring device on June 22, demonstrating continued expansion of connected medical technologies designed for everyday patient monitoring. The growing availability of clinically authorized wearable and sensor-based technologies is helping shift healthcare monitoring from occasional hospital measurements toward continuous and home-based health management.
02 Increasing Shift Toward Hospital-Level Care at Home Healthcare systems are increasingly exploring models in which selected patients receive hospital-level treatment in their homes. This shift requires reliable monitoring equipment, connected diagnostic devices, oxygen-delivery systems, infusion technologies, communication platforms, and other home-use medical equipment. Home-based care can also reduce pressure on hospital capacity while allowing suitable patients to recover in familiar environments. In March 2026, the U.S. Centers for Medicare & Medicaid Services confirmed that the Acute Hospital Care at Home initiative had been extended through September 30, 2030. CMS also released a second batch of program data, providing researchers with nearly five years of information from participating hospitals. The longer policy horizon gives hospitals and technology suppliers greater certainty to invest in equipment and digital infrastructure supporting care delivery outside conventional healthcare facilities.
01 Growing Chronic Disease Burden and Need for Continuous Patient Monitoring Diabetes, cardiovascular diseases, hypertension, respiratory disorders, neurological conditions, and other chronic illnesses often require regular monitoring rather than occasional clinical measurements. At the same time, aging populations are increasing demand for healthcare models that allow patients to manage conditions without frequent hospital visits. In July 2026, the U.S. FDA selected the first manufacturer for its Technology-Enabled Meaningful Patient Outcomes (TEMPO) for Digital Health Devices Pilot. Participating manufacturers are expected to provide technologies supporting care under the CMS ACCESS model for Americans managing certain chronic diseases.Greater integration of digital devices with chronic-care programs is expected to strengthen home healthcare devices market demand by connecting patient-generated health information with clinical decision-making.
01 High Device Costs and Affordability Barriers Advanced home healthcare equipment can require considerable spending on hardware, sensors, software subscriptions, replacement components, connectivity, maintenance, and clinical monitoring services. Portable oxygen concentrators, connected cardiac devices, continuous monitoring systems, and other sophisticated equipment may therefore remain difficult to afford without adequate insurance or reimbursement.The affordability problem can restrict the home healthcare devices market size, particularly in lower-income households and developing economies. Manufacturers must also balance advanced functionality with simple operation because home devices are frequently used by patients and caregivers without continuous professional supervision.Reducing device costs while maintaining accuracy, reliability, usability, and clinical performance remains an important barrier to wider adoption.
01 Development of Devices Designed Specifically to Prevent Hospital Readmissions Moving healthcare into the home creates opportunities for devices designed specifically around post-discharge monitoring rather than simply adapting hospital equipment for residential use.This transition is emerging as one of the important home healthcare devices market trends and provides opportunities for manufacturers capable of developing interoperable, easy-to-use, and clinically meaningful home technologies.Companies developing devices around post-discharge care and readmission prevention have opportunities to strengthen their home healthcare devices market share as healthcare delivery increasingly extends beyond hospitals.
01 Ensuring Interoperability, Usability, and Reliable Performance in Home Environments The home healthcare devices industry faces the challenge of making multiple devices operate safely and reliably outside controlled clinical settings. Patients may simultaneously use glucose monitors, blood pressure devices, wearables, medication systems, oxygen equipment, and smartphone applications from different manufacturers. Poor interoperability can fragment patient information and make it more difficult for healthcare professionals to obtain a complete view of patient health.Home environments also vary considerably in internet connectivity, electrical infrastructure, physical space, caregiver availability, and patient technical ability.Creating interoperable devices that remain secure, accurate, intuitive, and reliable across diverse residential environments will remain a major challenge as the home healthcare devices market expands.
June 2026 Philips expanded its connected home healthcare portfolio with new remote patient monitoring devices integrated with AI-enabled digital health platforms.
April 2026 GE HealthCare introduced advanced home monitoring solutions supporting chronic disease management and virtual patient care.
February 2026 Baxter International expanded its home healthcare device portfolio with enhanced home dialysis technologies designed to improve patient convenience and clinical outcomes.
October 2025 Omron Healthcare launched next-generation connected blood pressure monitors and remote health monitoring devices for home-based care.
July 2025 ResMed expanded its digital home healthcare ecosystem by introducing advanced connected sleep therapy devices with enhanced remote monitoring capabilities.